NeuroLief

Brain Neuromodulation Technology

Company Name
Updating Date
Neurotech Category
Market Category
Target Market
Technologies
Company Founded Year
Company Number of Employees
NeuroLief
02/07/2022
NeuroModulation
Digital & Health care
Clinical use (of cognitive, psychological, psychiatric, inc. early diagnosis)
Diagnostics
01/01/2013
"11-50"

Neurolief develops treatments for patients with chronic neurological and neuropsychiatric disorders. The company has created a digital therapeutics platform of clinically proven neuromodulation-based solutions that can be delivered to patients at home or in the community.



Neurolief's Relivion is a noninvasive, multichannel brain neuromodulation system for treating neurological and neuropsychiatric disorders. It offers precise, personalized care by delivering stimulation to six branches of the occipital and trigeminal nerves via three adaptive output channels. This creates a cumulative effect by releasing neurotransmitters in the brainstem to modulate the brain networks associated with pain and mood control.



The Relivion device is placed comfortably on the patient's head, where it stimulates the nerves. The connected e-Relief mobile app displays the treatment status and transmits information between patients and the cloud. The system is CE marked and has been granted a Breakthrough Device designation from the FDA.